posted by AHIP
on January 29, 2019
AHIP submitted a statement for the official record of a hearing held by the Senate Finance Committee on January 29, 2019 on “Drug Pricing in America: A Prescription for Change.”
Our statement explains that health insurance providers (and our pharmacy benefit manager partners) negotiate with manufacturers to make life-saving drugs available and affordable for patients. Still, we emphasize that additional steps are needed—at both the legislative and regulatory levels—to reduce list prices and achieve the goal of delivering more affordable medicines and lower costs for patients, consumers, employers, and taxpayers.
Our statement focuses on: